X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Panacea Biotech with Elder Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs ELDER PHARMA - Comparison Results

PANACEA BIOTECH    Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH ELDER PHARMA PANACEA BIOTECH/
ELDER PHARMA
 
P/E (TTM) x 80.6 -0.2 - View Chart
P/BV x 1.8 0.1 1,774.9% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 PANACEA BIOTECH   ELDER PHARMA
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-14
ELDER PHARMA
Jun-14
PANACEA BIOTECH/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs149380 39.1%   
Low Rs82188 43.8%   
Sales per share (Unadj.) Rs84.1491.2 17.1%  
Earnings per share (Unadj.) Rs-18.3-3.2 575.4%  
Cash flow per share (Unadj.) Rs-6.714.4 -46.5%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs83.7376.5 22.2%  
Shares outstanding (eoy) m61.2520.54 298.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.40.6 237.4%   
Avg P/E ratio x-6.3-89.3 7.1%  
P/CF ratio (eoy) x-17.219.7 -87.5%  
Price / Book Value ratio x1.40.8 182.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m7,0745,833 121.3%   
No. of employees `0002.8NA-   
Total wages/salary Rs m1,4492,179 66.5%   
Avg. sales/employee Rs Th1,874.1NM-  
Avg. wages/employee Rs Th527.0NM-  
Avg. net profit/employee Rs Th-407.7NM-  
INCOME DATA
Net Sales Rs m5,15410,089 51.1%  
Other income Rs m100257 38.9%   
Total revenues Rs m5,25410,346 50.8%   
Gross profit Rs m-766-792 96.8%  
Depreciation Rs m711361 196.8%   
Interest Rs m1,5032,756 54.5%   
Profit before tax Rs m-2,881-3,653 78.9%   
Minority Interest Rs m110-   
Prior Period Items Rs m-60-   
Extraordinary Inc (Exp) Rs m1,7713,713 47.7%   
Tax Rs m17125 13.4%   
Profit after tax Rs m-1,121-65 1,715.8%  
Gross profit margin %-14.9-7.8 189.4%  
Effective tax rate %-0.6-3.4 17.0%   
Net profit margin %-21.8-0.6 3,359.0%  
BALANCE SHEET DATA
Current assets Rs m3,8109,240 41.2%   
Current liabilities Rs m8,3659,998 83.7%   
Net working cap to sales %-88.4-7.5 1,176.9%  
Current ratio x0.50.9 49.3%  
Inventory Days Days15646 336.2%  
Debtors Days Days6760 112.2%  
Net fixed assets Rs m14,48010,124 143.0%   
Share capital Rs m61206 29.8%   
"Free" reserves Rs m9035,582 16.2%   
Net worth Rs m5,1277,734 66.3%   
Long term debt Rs m5,8324,889 119.3%   
Total assets Rs m19,43322,882 84.9%  
Interest coverage x-0.9-0.3 281.7%   
Debt to equity ratio x1.10.6 179.9%  
Sales to assets ratio x0.30.4 60.1%   
Return on assets %2.011.8 16.7%  
Return on equity %-21.9-0.8 2,588.0%  
Return on capital %3.622.3 16.3%  
Exports to sales %24.53.0 806.9%   
Imports to sales %10.20.4 2,383.7%   
Exports (fob) Rs m1,264307 412.2%   
Imports (cif) Rs m52543 1,217.6%   
Fx inflow Rs m1,539307 502.0%   
Fx outflow Rs m942125 751.8%   
Net fx Rs m597181 329.4%   
CASH FLOW
From Operations Rs m59911,754 5.1%  
From Investments Rs m-438-561 78.1%  
From Financial Activity Rs m-303-6,762 4.5%  
Net Cashflow Rs m-1414,432 -3.2%  

Share Holding

Indian Promoters % 74.5 39.6 188.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 7.5 8.0%  
FIIs % 1.3 16.8 7.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.6 36.1 65.4%  
Shareholders   10,259 16,479 62.3%  
Pledged promoter(s) holding % 35.1 77.6 45.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  WOCKHARDT LTD.  NOVARTIS  DR. DATSONS LABS  

Compare PANACEA BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Aug 23, 2017 03:36 PM

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 5-YR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS